< Back to previous page
Researcher
Karel Allegaert
- Disciplines:Paediatrics, Pharmacology not elsewhere classified, Neonatology
Affiliations
- Clinical Pharmacology and Pharmacotherapy (Division)
Member
From1 Oct 2019 → 30 Sep 2022 - Woman and Child (Division)
Member
From1 Apr 2013 → 30 Sep 2022
Infrastructure
1 - 1 of 1
Projects
1 - 10 of 21
- Using ‘real-world’ data to gain knowledge on medication safety during pregnancy: towards a ‘fit-for-purpose’ registration system on maternal medication use and mother-infant outcomes (BELpREG).From1 Oct 2023 → TodayFunding: BOF - postdoctoral mandates
- Antibacterial dose optimisation based on augmented renal clearance in adult critically ill patients and selected pediatric patientsFrom1 Oct 2021 → 30 Sep 2022Funding: BOF - postdoctoral mandates
- Exploration of the pharmacokinetics of clindamycin and its metabolites in special patients: from bioanalysis to clinical relevanceFrom1 Oct 2021 → 30 Sep 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Drug exposure through lactation: providing neonatal physiology to improve pharmacokinetic predictionsFrom21 Sep 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- External and Internal Drivers of Unhealthy AgeingFrom8 Sep 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Beyond optimising drug exposure: Pharmacodynamic models to bridge the gap between exposure and response to antimicrobial treatmentsFrom15 Jul 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- The development and validation of a prototype of a Belgian data registration system on medication use during pregnancy and lactation (BELpREG-project)From1 Jan 2021 → 31 Dec 2022Funding: IOF - technology validation in lab
- In vitro and in silico investigation of pharmacokinetics in neonates undergoing therapeutic hypothermiaFrom26 Nov 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- I-PREDICT: Innovative Physiology-based pharmacokinetic model to pREdict Drug exposure In neonates undergoing Cooling TherapyFrom1 Jan 2020 → 31 Dec 2023Funding: FWO research project (including WEAVE projects)
- A multidisciplinary study for the exploitation of biodegradable nanocarriers for targetted drug delivery to preterm newborn lungsFrom1 Oct 2018 → 30 Sep 2022Funding: Fund Recuperation Fiscal Exemption, IOF - Industrial Research Fund, BOF - Concerted Research Project from 1994
Publications
1 - 10 of 735
- Correction: Detailed statistical analysis plan for ALBINO: effect of Allopurinol in addition to hypothermia for hypoxic-ischemic Brain Injury on Neurocognitive Outcome - a blinded randomized placebo-controlled parallel group multicenter trial for superiority (phase III).(2024)
Authors: Karel Allegaert
Pages: 192 - Evaluating the relationship between the proportion of X-chromosome deletions and clinical manifestations in children with turner syndrome(2024)
Authors: Karel Allegaert
- Agreement Between a Colorimetric Assay and Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry for Quantifying Paracetamol Plasma Concentrations(2024)
Authors: Erwin Dreesen, Karel Allegaert, Lorenz Van der Linden, Jos Tournoy
- OSTEO18, a novel urinary proteomic signature, associated with osteoporosis in heart transplant recipients(2024)
Authors: Karel Allegaert
- Advanced approaches in pediatric clinical pharmacology(2024)
Authors: Karel Allegaert
- Letter to the editor re Davis et al., 2023: BELpREG, the first of its kind real-world data source on medication use in pregnancy in Belgium(2024)
Authors: Michael Ceulemans, Laure Sillis, Karel Allegaert, Annick Bogaerts, Maarten De Vos, Titia Hompes, Anne Smits, Kristel Van Calsteren, Jan Verbakel, Veerle Foulon
- Detailed statistical analysis plan for ALBINO: effect of Allopurinol in addition to hypothermia for hypoxic-ischemic Brain Injury on Neurocognitive Outcome - a blinded randomized placebo-controlled parallel group multicenter trial for superiority (phase III)(2024)
Authors: Karel Allegaert, Gunnar Naulaers
- The neonatal adverse event severity scale: current status, a stakeholders' assessment, and future perspectives(2024)
Authors: Karel Allegaert, Thomas Salaets
- The development of the Belgian paediatric clinical trial network(2024)
Authors: Karel Allegaert
Pages: 34 - 45 - Grading the level of evidence of neonatal pharmacotherapy: midazolam and phenobarbital as examples(2024)
Authors: Karel Allegaert, Anne Smits